Assessment of a universal preprocedural screening program for coronavirus disease 2019 (COVID-19)

Findings validated the value of the program through identification of a low rate of asymptomatic positive screens and procedural team adoption and sustainment. Findings may help inform decision making of like organizations attempting to enhance safety while resuming elective procedures.